by Sinan Oymacı 0

Hot Percepts
20160502 – Version 1.0


AbbVie, a major biopharmaceutical company acquired startup biotech company Stemcentrx worth up to $10.2 billion. Stemcentrx is developing drugs that target cancer stem cells, a particular type of cancer cell.

That acquisition is the second largest deal in venture capital history.



‘When we think to buy a new car, we go to 900+ decision points’ says a report from ‘Think with Google.’

It’s a long and time-consuming process. Do you know is there another buying ritual takes this kind of steps?



Infobesity: Overloaded information. We have tons of news, email, video, articles, scientific papers, research results every day. It is not possible to follow all of them. You begin to pass some of them or to try classification. Do not worry. You are not alone. Nobody handles this.



‘Needle-free blood draw.’ It comes from Google. The gadget removes a small amount of blood from the body. The patent, which is still pending, suggests the device may be used for testing blood sugar levels and be able to take blood automatically or manually for diabetics.



Sinan Oymaci

Sinan Oymacı

Industrial Eng. MBA. He has been in executive positions and establishment of new companies for long years in the ICT sector in national and international companies. He has also been involved in non-profit organizations and worked as a columnist in various publications. He is interested in technology, science and the future as well as art and philosophy. He supports new initiatives, start-ups and acts as a Technological Life Coach. Biohacking and transhumanism subjects are his special interests. He questions the human, life and looks for a clear definition to the concept of humanism. He is after the answer of the question 'How will Human 2.0 will look like?' .